Home > > > > > Report Detail

Artemisinin-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data

Publisher Name :
Date: 15-Jul-2019
No. of pages: 145

Report Summary

Artemisinin-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data offers a comprehensive analysis on Artemisinin industry, standing on the readers' perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Artemisinin 2014-2019, and development forecast 2020-2026

Main manufacturers/suppliers of Artemisinin worldwide and market share by regions, with company and product introduction, position in the Artemisinin market

Market status and development trend of Artemisinin by types and applications

Cost and profit status of Artemisinin, and marketing status

Market growth drivers and challenges

The report segments the global Artemisinin market as:

Global Artemisinin Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2014-2026):

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)

Asia Pacific (China, Japan, India, Southeast Asia and Australia)

Latin America (Brazil, Argentina and Colombia)

Middle East and Africa

Global Artemisinin Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2014-2026):

Extraction from Artemisia annua

Semisynthetic Artemisinin

Global Artemisinin Market: Application Segment Analysis (Consumption Volume and Market Share 2014-2026; Downstream Customers and Market Analysis)

Antimalarial Injections

Antimalarial Tablets

Global Artemisinin Market: Manufacturers Segment Analysis (Company and Product introduction, Artemisinin Sales Volume, Revenue, Price and Gross Margin):

Sanofi

KPC Pharmaceuticals

Kerui nanhai

Guangxi xiancaotang

Guilin Pharmaceutical

Natural Bio-engineering

BIONEXX

CAT KHANH

BEEPZ

Novanat Bioresource

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Artemisinin-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data

Table of Contents

Chapter 1 Overview of Artemisinin
1.1 Definition of Artemisinin in This Report
1.2 Commercial Types of Artemisinin
1.2.1 Extraction from Artemisia annua
1.2.2 Semisynthetic Artemisinin
1.3 Downstream Application of Artemisinin
1.3.1 Antimalarial Injections
1.3.2 Antimalarial Tablets
1.4 Development History of Artemisinin
1.5 Market Status and Trend of Artemisinin 2014-2026
1.5.1 Global Artemisinin Market Status and Trend 2014-2026
1.5.2 Regional Artemisinin Market Status and Trend 2014-2026

Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Artemisinin 2014-2019
2.2 Sales Market of Artemisinin by Regions
2.2.1 Sales Volume of Artemisinin by Regions
2.2.2 Sales Value of Artemisinin by Regions
2.3 Production Market of Artemisinin by Regions
2.4 Global Market Forecast of Artemisinin 2020-2026
2.4.1 Global Market Forecast of Artemisinin 2020-2026
2.4.2 Market Forecast of Artemisinin by Regions 2020-2026

Chapter 3 Global Market Status and Forecast by Types
3.1 Sales Volume of Artemisinin by Types
3.2 Sales Value of Artemisinin by Types
3.3 Market Forecast of Artemisinin by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Global Sales Volume of Artemisinin by Downstream Industry
4.2 Global Market Forecast of Artemisinin by Downstream Industry

Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
5.1 North America Artemisinin Market Status by Countries
5.1.1 North America Artemisinin Sales by Countries (2014-2019)
5.1.2 North America Artemisinin Revenue by Countries (2014-2019)
5.1.3 United States Artemisinin Market Status (2014-2019)
5.1.4 Canada Artemisinin Market Status (2014-2019)
5.1.5 Mexico Artemisinin Market Status (2014-2019)
5.2 North America Artemisinin Market Status by Manufacturers
5.3 North America Artemisinin Market Status by Type (2014-2019)
5.3.1 North America Artemisinin Sales by Type (2014-2019)
5.3.2 North America Artemisinin Revenue by Type (2014-2019)
5.4 North America Artemisinin Market Status by Downstream Industry (2014-2019)

Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
6.1 Europe Artemisinin Market Status by Countries
6.1.1 Europe Artemisinin Sales by Countries (2014-2019)
6.1.2 Europe Artemisinin Revenue by Countries (2014-2019)
6.1.3 Germany Artemisinin Market Status (2014-2019)
6.1.4 UK Artemisinin Market Status (2014-2019)
6.1.5 France Artemisinin Market Status (2014-2019)
6.1.6 Italy Artemisinin Market Status (2014-2019)
6.1.7 Russia Artemisinin Market Status (2014-2019)
6.1.8 Spain Artemisinin Market Status (2014-2019)
6.1.9 Benelux Artemisinin Market Status (2014-2019)
6.2 Europe Artemisinin Market Status by Manufacturers
6.3 Europe Artemisinin Market Status by Type (2014-2019)
6.3.1 Europe Artemisinin Sales by Type (2014-2019)
6.3.2 Europe Artemisinin Revenue by Type (2014-2019)
6.4 Europe Artemisinin Market Status by Downstream Industry (2014-2019)

Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
7.1 Asia Pacific Artemisinin Market Status by Countries
7.1.1 Asia Pacific Artemisinin Sales by Countries (2014-2019)
7.1.2 Asia Pacific Artemisinin Revenue by Countries (2014-2019)
7.1.3 China Artemisinin Market Status (2014-2019)
7.1.4 Japan Artemisinin Market Status (2014-2019)
7.1.5 India Artemisinin Market Status (2014-2019)
7.1.6 Southeast Asia Artemisinin Market Status (2014-2019)
7.1.7 Australia Artemisinin Market Status (2014-2019)
7.2 Asia Pacific Artemisinin Market Status by Manufacturers
7.3 Asia Pacific Artemisinin Market Status by Type (2014-2019)
7.3.1 Asia Pacific Artemisinin Sales by Type (2014-2019)
7.3.2 Asia Pacific Artemisinin Revenue by Type (2014-2019)
7.4 Asia Pacific Artemisinin Market Status by Downstream Industry (2014-2019)

Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
8.1 Latin America Artemisinin Market Status by Countries
8.1.1 Latin America Artemisinin Sales by Countries (2014-2019)
8.1.2 Latin America Artemisinin Revenue by Countries (2014-2019)
8.1.3 Brazil Artemisinin Market Status (2014-2019)
8.1.4 Argentina Artemisinin Market Status (2014-2019)
8.1.5 Colombia Artemisinin Market Status (2014-2019)
8.2 Latin America Artemisinin Market Status by Manufacturers
8.3 Latin America Artemisinin Market Status by Type (2014-2019)
8.3.1 Latin America Artemisinin Sales by Type (2014-2019)
8.3.2 Latin America Artemisinin Revenue by Type (2014-2019)
8.4 Latin America Artemisinin Market Status by Downstream Industry (2014-2019)

Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
9.1 Middle East and Africa Artemisinin Market Status by Countries
9.1.1 Middle East and Africa Artemisinin Sales by Countries (2014-2019)
9.1.2 Middle East and Africa Artemisinin Revenue by Countries (2014-2019)
9.1.3 Middle East Artemisinin Market Status (2014-2019)
9.1.4 Africa Artemisinin Market Status (2014-2019)
9.2 Middle East and Africa Artemisinin Market Status by Manufacturers
9.3 Middle East and Africa Artemisinin Market Status by Type (2014-2019)
9.3.1 Middle East and Africa Artemisinin Sales by Type (2014-2019)
9.3.2 Middle East and Africa Artemisinin Revenue by Type (2014-2019)
9.4 Middle East and Africa Artemisinin Market Status by Downstream Industry (2014-2019)

Chapter 10 Market Driving Factor Analysis of Artemisinin
10.1 Global Economy Situation and Trend Overview
10.2 Artemisinin Downstream Industry Situation and Trend Overview

Chapter 11 Artemisinin Market Competition Status by Major Manufacturers
11.1 Production Volume of Artemisinin by Major Manufacturers
11.2 Production Value of Artemisinin by Major Manufacturers
11.3 Basic Information of Artemisinin by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Artemisinin Major Manufacturer
11.3.2 Employees and Revenue Level of Artemisinin Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch

Chapter 12 Artemisinin Major Manufacturers Introduction and Market Data
12.1 Sanofi
12.1.1 Company profile
12.1.2 Representative Artemisinin Product
12.1.3 Artemisinin Sales, Revenue, Price and Gross Margin of Sanofi
12.2 KPC Pharmaceuticals
12.2.1 Company profile
12.2.2 Representative Artemisinin Product
12.2.3 Artemisinin Sales, Revenue, Price and Gross Margin of KPC Pharmaceuticals
12.3 Kerui nanhai
12.3.1 Company profile
12.3.2 Representative Artemisinin Product
12.3.3 Artemisinin Sales, Revenue, Price and Gross Margin of Kerui nanhai
12.4 Guangxi xiancaotang
12.4.1 Company profile
12.4.2 Representative Artemisinin Product
12.4.3 Artemisinin Sales, Revenue, Price and Gross Margin of Guangxi xiancaotang
12.5 Guilin Pharmaceutical
12.5.1 Company profile
12.5.2 Representative Artemisinin Product
12.5.3 Artemisinin Sales, Revenue, Price and Gross Margin of Guilin Pharmaceutical
12.6 Natural Bio-engineering
12.6.1 Company profile
12.6.2 Representative Artemisinin Product
12.6.3 Artemisinin Sales, Revenue, Price and Gross Margin of Natural Bio-engineering
12.7 BIONEXX
12.7.1 Company profile
12.7.2 Representative Artemisinin Product
12.7.3 Artemisinin Sales, Revenue, Price and Gross Margin of BIONEXX
12.8 CAT KHANH
12.8.1 Company profile
12.8.2 Representative Artemisinin Product
12.8.3 Artemisinin Sales, Revenue, Price and Gross Margin of CAT KHANH
12.9 BEEPZ
12.9.1 Company profile
12.9.2 Representative Artemisinin Product
12.9.3 Artemisinin Sales, Revenue, Price and Gross Margin of BEEPZ
12.10 Novanat Bioresource
12.10.1 Company profile
12.10.2 Representative Artemisinin Product
12.10.3 Artemisinin Sales, Revenue, Price and Gross Margin of Novanat Bioresource

Chapter 13 Upstream and Downstream Market Analysis of Artemisinin
13.1 Industry Chain of Artemisinin
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

Chapter 14 Cost and Gross Margin Analysis of Artemisinin
14.1 Cost Structure Analysis of Artemisinin
14.2 Raw Materials Cost Analysis of Artemisinin
14.3 Labor Cost Analysis of Artemisinin
14.4 Manufacturing Expenses Analysis of Artemisinin

Chapter 15 Report Conclusion

Chapter 16 Research Methodology and Reference
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
  • Global Dihydroartemisinin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......
  • Global Artemisinin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......
  • Dihydroartemisinin - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99
    The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......
  • Global Artemisinin Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Artemisinin Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......
  • Global Artemisinin Market Insights, Forecast to 2029
    Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108
    Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs